Eclalbasaponin I
CAS No. 158511-59-2
Eclalbasaponin I( —— )
Catalog No. M23688 CAS No. 158511-59-2
Eclalbasaponin I has anti-oxidative, and antitumor activities, it reduces oxidative stress-induced neural cell death by autophagy activation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 170 | In Stock |
|
10MG | 282 | In Stock |
|
25MG | 475 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEclalbasaponin I
-
NoteResearch use only, not for human use.
-
Brief DescriptionEclalbasaponin I has anti-oxidative, and antitumor activities, it reduces oxidative stress-induced neural cell death by autophagy activation.
-
DescriptionEclalbasaponin I has anti-oxidative, and antitumor activities, it reduces oxidative stress-induced neural cell death by autophagy activation, it can dose-dependently inhibit the proliferation of hepatoma cell smmc-7721 with the IC(50) value of 111.1703 ug/ml.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number158511-59-2
-
Formula Weight796.98
-
Molecular FormulaC42H68O14
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (125.47 mM)
-
SMILESCC(C)(CC[C@]12C(O[C@@H]([C@@H]([C@H]3O)O)O[C@H](CO)[C@H]3O)=O)C[C@H]2C2=CC[C@H]([C@@](C)(CC3)[C@@H](CC4)C(C)(C)[C@H]3O[C@@H]([C@@H]([C@H]3O)O)O[C@H](CO)[C@H]3O)[C@]4(C)[C@]2(C)C[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Eclipta prostrata L. phytochemicals: isolation, structure elucidation, and their antitumor activity.Food Chem Toxicol. 2012 Nov;50(11):4016-22.
molnova catalog
related products
-
Lapaquistat
A novel potent, competitive, orally active squalene synthase inhibitor with IC50 of 78 nM.
-
(25R)-Spirost-4-ene-...
(25R)-Spirost-4-ene-3,12-dione is a natural product.
-
JI-101
JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4).